IN8BIO (INAB) awards 60,000 stock options to President and COO Kate Rochlin
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IN8BIO, INC. reported that President and COO Kate Rochlin received a grant of employee stock options covering 60,000 shares of common stock. The options have an exercise price of $1.58 per share and expire on May 9, 2036.
These compensation-related options were awarded with no cash paid by the executive at grant. According to the vesting schedule, 25% of the option shares vest on each of November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028, as long as she continues providing service through each date. After this grant, she holds options for 60,000 underlying shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Rochlin Kate
Role
President and COO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 60,000 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 60,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 60,000 options
Exercise price: $1.58 per share
Expiration date: May 9, 2036
+3 more
6 metrics
Option grant size
60,000 options
Employee stock option award to President and COO
Exercise price
$1.58 per share
Strike price of employee stock options
Expiration date
May 9, 2036
Option term end date
Post-grant option holdings
60,000 options
Total derivative shares following transaction
Initial vesting date
November 9, 2026
First 25% of options vest
Final vesting date
May 9, 2028
Last 25% of options vest
Key Terms
Employee Stock Option (right to buy), exercise price, vest, expiration date, +1 more
5 terms
Employee Stock Option (right to buy) financial
"security_title: Employee Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 1.5800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"shares subject to the option shall vest on each of November 9, 2026"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
expiration date financial
"expiration_date: 2036-05-09T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
derivative securities financial
"transaction_type: derivative"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What did IN8BIO (INAB) disclose about President and COO Kate Rochlin?
IN8BIO disclosed that President and COO Kate Rochlin received a grant of stock options for 60,000 shares. These options are part of her equity compensation and give her the right to buy common stock at a fixed price if vesting conditions are met.
What is the exercise price and expiration date of Kate Rochlin’s IN8BIO options?
The options have an exercise price of $1.58 per share and expire on May 9, 2036. This fixed price lets her buy shares at $1.58 if she exercises before expiration and after the options vest.
How do Kate Rochlin’s IN8BIO (INAB) stock options vest over time?
The options vest in four equal installments of 25% each on November 9, 2026, May 9, 2027, November 9, 2027 and May 9, 2028. Vesting requires that she continue providing service through each scheduled vesting date.